BSE:532531 | NSE:STAREQ | 58888:strides | IND:Pharma - Indian | ISIN code:INE939A01011 | SECT:Pharmaceuticals
The Cash Flow Statement of Strides Pharma Science Ltd. presents the key Cash Flow ratios, its comparison with the sector peers and 5 years of Cash Flow Statement.
Rs (in Crores)
|Profit Before Tax||108.33||915.80||182.65||189.29||669.03|
|Net Cash Flow from Operating Activity||39.97||65.59||411.74||.00||207.39|
|Net Cash Used in Investing Activity||-166.06||447.36||-344.05||.00||304.95|
|Net Cash Used in Financing Activity||123.26||-706.77||-67.24||.00||-802.21|
|Net Inc/Dec In Cash and Cash Equivalent||-2.83||-193.82||.45||590.02||-289.87|
|Cash and Cash Equivalent - Beginning of the Year||72.30||266.12||280.07||227.75||515.69|
|Cash and Cash Equivalent - End of the Year||69.47||72.30||280.52||817.78||225.82|
Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service